Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

NCT00481325 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: pexacerfont
DRUG: escitalopram
DRUG: placebo

Sponsor

Bristol-Myers Squibb